QQ客服 官方微博 反馈留言

	Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment
	Li, Xu; Jin, Qinglong; Xu, Hongqin; Zhang, Zetian; Zhou, Hongjie; Yan, Dongqing; Li, Dongmei; Gao, Pujun; Niu, Junqi
刊名	EXPERIMENTAL AND THERAPEUTIC MEDICINE
	2017
卷号	13期号:6
关键词	liver fibrosis qHBsAg entecavir chronic hepatitis B
ISSN号	1792-0981
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3539612
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Li, Xu,Jin, Qinglong,Xu, Hongqin,et al. Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment[J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE,2017,13(6).
APA	Li, Xu.,Jin, Qinglong.,Xu, Hongqin.,Zhang, Zetian.,Zhou, Hongjie.,...&Niu, Junqi.(2017).Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment.EXPERIMENTAL AND THERAPEUTIC MEDICINE,13(6).
MLA	Li, Xu,et al."Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment".EXPERIMENTAL AND THERAPEUTIC MEDICINE 13.6(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。